vimarsana.com

Latest Breaking News On - Nektar therapeutics - Page 12 : vimarsana.com

Chimerix Appoints Lisa Decker to Board of Directors

Chimerix Appoints Lisa Decker to Board of Directors
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

Mike-andriole
Lisa-decker
Nektar-therapeutics
Business-development
Tufts-university-school-of-medicine
University-of-massachusetts-medical-school
College-of-the-holy-cross
Office-of-technology-management
Atreca-inc
Chief-business-officer
Catherine-gilliss-phd
Chimerix-board

Inspire Medical adds Intuitive CMO Dr. Myriam Curet to its board

Inspire Medical Systems (NYSE:INSP) announced today that it appointed Dr. Myriam J. Curet as an independent board director.

Tim-herbert
Stanford-university
Nektar-therapeutics
University-of-new-mexico
Philips
Medical-design
Inspire-medical

Inspire Medical Systems (INSP) Announces Appointment of Seasoned Medical Device Executive Myriam J. Curet, M.D. to its Board of Directors

Inspire Medical Systems (INSP) Announces Appointment of Seasoned Medical Device Executive Myriam J. Curet, M.D. to its Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
Myriamj-curet
Tim-herbert
University-of-chicago
University-of-new-mexico
Systems-inc
Professor-of-surgery-at-stanford-university
Harvard-medical-school
Nektar-therapeutics
Inspire-medical-systems
Chief-executive-officer
Inspire-medical

Nektar Therapeutics (NASDAQ:NKTR) Receives $3.00 Consensus Price Target from Brokerages

Shares of Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) have been assigned an average rating of “Reduce” from the seven brokerages that are presently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, four have issued a hold recommendation and one has assigned a buy recommendation to […]

United-states
Syntax-advisors
Life-insurance-co
Nektar-therapeutics
Verition-fund-management
Halbert-hargrove-global-advisors
Jpmorgan-chase-co
Get-free-report
Marketbeat-ratings
Fund-management
Hargrove-global-advisors

Nektar Therapeutics (NASDAQ:NKTR) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) in a report released on Wednesday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Several other equities research analysts also recently weighed in on NKTR. TD Cowen upgraded shares of Nektar Therapeutics from a market perform rating to an […]

United-states
Jpmorgan-chase-co
Jacobs-levy-equity-management-inc
Citigroup-inc
Capital-partners
Nektar-therapeutics
Free-report
Get-free-report
Levy-equity-management
Nektar-therapeutics-daily
Nasdaq-nktr

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.